Leahlyn Mamuyac presents at the Stanford CVI 2022 Summer Research Symposium
Leahlyn Mamuyac
Leahlyn presented data gathered as a part of her summer research experience in the Blau lab working with Asuka Eguchi, PhD. Leahlyn's talk was entitled Microdystrophin gene therapy for Duchenne Muscular Dystrophy cardiomyocytes and it provided insights into her data comparing the ability of three dystrophin variants that are currently in clinical trials to rescue DMD-associated pathological phenotypes in cardiomyocytes differentiated from human induced pluripotent stem cells (iPSCs). The event program, including Leahlyn's abstract, is available here.